$29.76
-0.52-1.72%
近くで: Nov 16, 4:00 PM EST
$29.76
N/A
時間外: 4:00 PM EST

Avalyn Pharma (AVLN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.67 | $-0.73 | 8.22 % |
| Q2 | Aug 12, 2026 | $-0.98 | $-0.66 | -48.5 % |
| Q1 | Jun 3, 2026 | $-21.83 | $-16.38 | -33.3 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-0.73 | $-0.66 | $-16.38 |
| Actual | $-0.67 | $-0.98 | $-21.83 |
| Surprise | +8.22% | -48.5% | -33.3% |
| Revenue | |||
| Estimate | — | — | — |
| Actual | $0 | $0 | $0 |
| Surprise | — | — | — |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.71 | $-0.73 |
| Revenue | ||
| Consensus | — | — |